Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Oct;114(1):78-86.
doi: 10.1046/j.1365-2249.1998.00689.x.

Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness

Affiliations

Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness

A Kumar et al. Clin Exp Immunol. 1998 Oct.

Abstract

Immune unresponsiveness in HIV-1 infection can result from impaired signals delivered by the costimulatory CD28-B7 pathway and the altered production of immunoregulatory cytokines, in particular IL-10, whose production is altered in HIV-1 infection. In this study we investigate IL-10 regulation in T cells and monocytes from HIV+ individuals, and its association with CD28-mediated T cell proliferation. IL-10 production as analysed in T cell- and monocyte-depleted peripheral blood mononuclear cells (PBMC), and by intracellular staining at the single-cell level, reveals a defect in IL-10 production by CD4+ and CD8+ T cells, whereas monocytes constitute the major IL-10-producing cell type. To investigate the impact of IL-10 on immune responsiveness, CD28-mediated proliferative responses in HIV+ individuals were correlated with PHA-induced IL-10 production. CD4+ T cells expressed CD28, yet exhibited markedly reduced CD28-mediated cell proliferation. This CD28-mediated CD4+ T cell proliferation was found to be inversely associated with the levels of PHA-induced IL-10 production and could be restored, at least in part, by anti-IL-10 antibodies. These results suggest that IL-10 production is differentially regulated in T cells and monocytes of HIV+ individuals, and that IL-10 may have a role in inducing immune unresponsiveness by modulating the CD28-B7 pathway.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a). Production of IL-10 by phytohaemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMC) from HIV+ and HIV individuals. PBMC from 37 HIV+ and 16 HIV individuals were cultured at a concentration of 2 × 106/ml for 48 h with PHA (1:50 final dilution) and supernatants were collected and assayed for IL-10 production by ELISA. IL-10 levels are reported as pg/ml (mean ± s.e.m.). PBMC from HIV+ individuals were stratified into low IL-10 producers (IL-10 stimulation index (SI) < 4) and IL-10 producers (IL-10 SI > 4). (b) Production of IL-2, IL-10 and IL-12 by PBMC from HIV+ low IL-10 producers and HIV normal controls. PBMC from 15 HIV+ low IL-10 producers were stimulated with PHA and analysed for IL-10 (IL-10-PHA) and IL-2 production (IL-2-PHA). PBMC from these patients were also stimulated with lipopolysaccharide (LPS) (1 μg/ml) and analysed for IL-10 (IL-10-LPS) and IL-12 (IL-12-LPS) production. The levels of IL-2, IL-10, and IL-12 are reported as pg/ml (mean ± s.e.m.).
Fig. 2
Fig. 2
Effect of monocyte (a) and T cell (b) depletion from peripheral blood mononuclear cells (PBMC) of HIV+ and HIV individuals on IL-10 production following stimulation with phytohaemagglutinin (PHA). PBMC from six HIV+ and six HIV individuals were depleted of either T cells or monocytes by using anti-CD2 conjugated immunobeads and by l-leucine-methyl ester (L-LME) treatment, respectively. The depleted and undepleted PBMC were stimulated with PHA for 2 days and supernatants were analysed for IL-10 production by ELISA. The results from two representative HIV+ and one HIV individual are shown.
Fig. 3
Fig. 3
Analysis of IL-10 expression by T cells and monocytes of HIV+ and HIV individuals by intracellular staining. Peripheral blood mononuclear cells (PBMC) (2 × 106 cells/ml) from six HIV+ and five HIV individuals were stimulated with phytohaemagglutinin (PHA) for 36 h and analysed for IL-10 production at the single-cell level by intracellular staining using three-colour flow cytometry as described in Materials and Methods. CD4+ and CD8+ T cells (stained with Quantum Red-labelled anti-CD4 and anti-CD8 antibodies) and CD15+ monocytes (stained with FITC-labelled anti-CD15 antibodies) were analysed for IL-10 expression (counter-stained with PE-labelled anti-IL-10 antibodies). Results of IL-10 expression by CD4+ and CD8+ T cells (a) and CD15+ monocytes (b) of one representative HIV+ and HIV individual are shown. Medium and PHA indicate unstimulated and PHA-stimulated cells, respectively. Unstimulated cells were also stained with isotype-matched antibody of irrelevant specificity and exhibited similar patterns of staining as for PHA-stimulated cells (data not shown).
Fig. 4
Fig. 4
Proliferative response of CD4+ mononuclear cells (CD4+ T cells and monocytes) from peripheral blood mononuclear cells (PBMC) of HIV+ and HIV individuals in response to suboptimal concentrations of phytohaemagglutinin (PHA) and anti-CD28 antibodies. CD4+ cells from PBMC of four HIV+ (HIV-1 to HIV-4) and two HIV (N-1 and N-2) individuals were stimulated with a suboptimal concentration of PHA (1:200 final dilution) and anti-CD28 antibodies (1:100 final dilution) followed by measurement of cell proliferation by 3H-thymidine incorporation. ▪, Cells stimulated with a suboptimal concentration of PHA alone; □, cells stimulated with a suboptimal concentration of PHA and anti-CD28 antibodies.
Fig. 5
Fig. 5
Correlation of IL-10 production by phytohaemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMC) from HIV+ low IL-10 producers and IL-10 producers with proliferative responses of CD4+ mononuclear cells to anti-CD28 antibodies and PHA. CD4+ mononuclear cells (2 × 104/ml) from HIV+ individuals were stimulated with suboptimal concentrations of PHA and anti-CD28 antibodies and cell proliferation was measured as described in the legend to Fig. 6. PBMC from the same HIV-infected individuals were simultaneously stimulated with PHA (1:50 final dilution) for 48 h and supernatants were analysed for IL-10 production. The cell proliferation stimulation index (SI; ratio of 3H-thymidine incorporation in the presence of PHA and anti-CD28 antibodies to that observed in the presence of PHA alone) was correlated with the levels of IL-10 SI (ratio of the levels of IL-10 produced following stimulation with PHA to that produced by unstimulated PBMC) in low IL-10 producers (IL-10 SI < 4) and IL-10 producers (IL-10 SI > 4).
Fig. 6
Fig. 6
Effect of anti-IL-10 antibodies on the CD28-induced proliferative responses of CD4+ mononuclear cells. CD4+ mononuclear cells from HIV+ low IL-10 producers were stimulated with suboptimal concentrations of phytohaemagglutinin (PHA) and anti-CD28 antibodies in the presence of anti-IL-10 antibodies (10 μg/ml). Cells were pulsed with 3H-thymidine after 48 h of culture followed by measurement of 3H-thymidine incorporation 16 h later. Results from two representative HIV+ individuals are shown.

References

    1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature. 1996;384:529–34. - PubMed
    1. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993;57:183–289. - PMC - PubMed
    1. Giorgi JV, Fahey JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, Detels R. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol. 1987;138:3725–30. - PubMed
    1. Clerici M, Herkin FT, Venzon DJ, Blatt S, Hendrix GW, Wynn T, Shearer GM. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993;91:789–95. - PMC - PubMed
    1. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, Shearer GM. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest. 1989;84:1892–9. - PMC - PubMed

Publication types